Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind,

M Kumpu1, R A Kekkonen, H Kautiainen

  • 1Valio Ltd, Helsinki, Finland.

Insights

Daily consumption of probiotic Lactobacillus rhamnosus GG (GG) in milk reduced respiratory illness in children attending day care, particularly when GG was detected in fecal samples. Further research is needed to confirm this probiotic effect.

Area of Science:

  • Pediatrics
  • Microbiology
  • Immunology

Background:

  • Respiratory illnesses are common in children attending day care.
  • Probiotics, such as Lactobacillus rhamnosus GG (GG), are being investigated for their potential health benefits.

Purpose of the Study:

  • To evaluate the effect of long-term daily consumption of milk containing probiotic Lactobacillus rhamnosus GG (GG) on reducing respiratory illness in children.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial involved 523 children aged 2-6 years in Finnish day care centers.
  • Participants consumed either regular milk or milk with GG for 28 weeks, with daily symptom recording by parents.
  • Analysis included primary outcome data from 501 subjects and completed cases from 128 subjects with confirmed GG recovery in fecal samples.

Main Results:

  • In the total population, there was no significant difference in respiratory symptom days between the GG and placebo groups (IRR 0.97; P=0.098).
  • However, in the subgroup of completed cases (with fecal GG recovery), the GG group experienced fewer symptom days (IRR 0.83; P<0.001).

Conclusions:

  • Lactobacillus rhamnosus GG (GG) consumption demonstrated a reduction in respiratory illness occurrence in children within the completed cases subgroup.
  • The study highlights the need for further clinical trials to clarify the link between probiotic fecal recovery and symptom prevalence in children.
Abstract

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...